A novel microphysiological system using ovarian follicles enables physiologically relevant three-dimensional angiogenesis ...
International researchers have mapped the structure of the thromboxase Aâ‚‚ receptor using cryo-electron microscopy, revealing some unexpected activation mechanisms.
Insilico Medicine has nominated ISM6200, a preclinical drug candidate designed using generative AI to target NR3C1, a receptor involved in cortisol regulation.
All Opinion and interviews articles in Drug Target Review ...
10x Genomics has launched Atera, an in situ spatial biology platform delivering whole-transcriptome analysis with single-cell sensitivity at large scale, designed to overcome traditional limitations ...
A new study has revealed that age-related clonal haematopoiesis accelerates aortic aneurysm growth through RANK/RANKL signalling, meaning that repurposing osteoporosis drugs targeting this pathway ...
ELRIG is launching its first major US event, Drug Discovery USA 2026, at Pfizer’s Cambridge, Massachusetts facility on 16–17 June. The free-to-attend conference will bring together European and ...
NAMs are now part of early drug discovery, but adoption remains uneven. Join leading experts for a discussion on current applications, limitations and what is required for wider use. The session ...
The company will showcase translational research using patient-derived models and integrated molecular data across multiple cancer types and therapeutic modalities at the American Association for ...
The new platform enables researchers to analyse gene expression and cellular organisation within intact tissue at single-cell resolution, supporting large-scale studies across fresh-frozen and FFPE ...
New research published in Nature Communications shows how generative AI can be used to design complex dual-action cancer drug candidates. Insilico Medicine has developed a PKMYT1 degrader that both ...
New research from Shanghai Pulmonary Hospital outlines how lactate-driven lactylation acts as a metabolic switch controlling ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results